Tudor Investment Corp’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-37,952
| Closed | -$126K | – | 1520 |
|
|
2023
Q4 | $126K | Sell |
37,952
-17,569
| -32% | -$58.5K | ﹤0.01% | 1366 |
|
|
2023
Q3 | $208K | Buy |
55,521
+12,834
| +30% | +$48K | ﹤0.01% | 1327 |
|
|
2023
Q2 | $182K | Buy |
42,687
+683
| +2% | +$2.92K | ﹤0.01% | 1384 |
|
|
2023
Q1 | $287K | Buy |
42,004
+5,176
| +14% | +$35.4K | ﹤0.01% | 1285 |
|
|
2022
Q4 | $292K | Buy |
36,828
+13,218
| +56% | +$105K | 0.01% | 1264 |
|
|
2022
Q3 | $227K | Sell |
23,610
-151,480
| -87% | -$1.46M | ﹤0.01% | 1375 |
|
|
2022
Q2 | $1.27M | Sell |
175,090
-13,611
| -7% | -$98.6K | 0.03% | 689 |
|
|
2022
Q1 | $2.44M | Sell |
188,701
-7,521
| -4% | -$97.1K | 0.06% | 445 |
|
|
2021
Q4 | $3.13M | Buy |
+196,222
| New | +$3.13M | 0.05% | 408 |
|
|
2020
Q1 | – | Sell |
-16,491
| Closed | -$297K | – | 1077 |
|
|
2019
Q4 | $297K | Buy |
+16,491
| New | +$297K | 0.01% | 863 |
|
|
2019
Q2 | – | Sell |
-30,809
| Closed | -$420K | – | 1106 |
|
|
2019
Q1 | $420K | Buy |
+30,809
| New | +$420K | 0.02% | 757 |
|
|
2017
Q4 | – | Sell |
-19,502
| Closed | -$260K | – | 1086 |
|
|
2017
Q3 | $260K | Sell |
19,502
-9,179
| -32% | -$122K | 0.01% | 861 |
|
|
2017
Q2 | $412K | Buy |
28,681
+5,458
| +24% | +$78.4K | 0.01% | 630 |
|
|
2017
Q1 | $491K | Buy |
23,223
+8,827
| +61% | +$187K | 0.02% | 693 |
|
|
2016
Q4 | $405K | Buy |
14,396
+3,726
| +35% | +$105K | 0.01% | 822 |
|
|
2016
Q3 | $286K | Sell |
10,670
-630
| -6% | -$16.9K | 0.01% | 1033 |
|
|
2016
Q2 | $191K | Buy |
+11,300
| New | +$191K | ﹤0.01% | 1246 |
|